Healthcare leaders reveal 2025’s biggest surprises, part two
Healthcare leaders reveal 2025’s biggest surprises, part two | MobiHealthNews
Skip to main content…
Continue Reading
Category: Latest News
Healthcare leaders reveal 2025’s biggest surprises, Part 2
Healthcare leaders reveal 2025’s biggest surprises, Part 2 | MobiHealthNews
Skip to main content…
Continue Reading
WellSky and uMed expand home-based clinical trial access nationwide
WellSky and uMed expand home-based clinical trial access nationwide | MobiHealthNews
Skip to main content…
Continue Reading
PwC 2026 Outlook: Health Services M&A Poised for Rebound as AI Becomes “Core Driver” of Value
What You Should Know:
– According to PwC’s 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
– The report…
Continue Reading
Catalyzing trust through interoperability: compliance as assurance
Catalyzing trust through interoperability: compliance as assurance | Healthcare IT News
Skip to main content…
Continue Reading
Mass General Brigham Spins Out AIwithCare: New AI Tool Doubles Clinical Trial Enrollment Rates
What You Should Know:
– Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly outperformed manual screening for determining…
Continue Reading
Ritten Raises $35M to Scale AI-Powered Behavioral Health Platform
What You Should Know:
– Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors…
Continue Reading
Infinitus Systems Launches Next-Gen ”Agentic” Clinical AI for Patient Conversations
What You Should Know:
– Infinitus Systems, Inc., healthcare’s leading agentic communications partner powering more than 100 million minutes of conversations, today launched its next generation of clinical AI agents for patient-facing conversations.
– These new agents…
Continue Reading
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
– MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental…
Continue Reading